|

INDUSTRY NEWS
Connexon Creative Launches Cord Blood News
Cord Blood News is a weekly e-newsletter that keeps members of the cord blood community informed by providing the latest news from all areas of the field, including its science, research, policy, and business.
iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming
iZumi Bio, Inc. and Pierian, Inc. recently announced they have merged to form a new company, iPierian, Inc. Building on the iZumi infrastructure and vision, the company is focused on the application of cellular reprogramming to change the paradigm of drug discovery.
Yissum Licenses Stem Cell Technologies for Spinal Therapy to TheraCell, Inc.
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., recently announced that it has licensed a novel package of stem cell related technologies to TheraCell, Inc., which will further develop and commercialize the technology for advanced regenerative medicine procedures such as spinal fusion.
Start-Ups Say Innovation Doesn't Grow on Trees
When nearly $10 billion in stimulus funds went to the NIH this year, a last-minute change in the legislation exempted the agency from setting aside 2.8 percent of its research budget for small businesses and the commercialization of technologies developed at universities.
Stem Cell Therapeutics Announces Issuance of Patents in India
Stem Cell Therapeutics Corp. has been issued two patents in India: Indian Patent No. 229684 entitled, "Combined Regulation of Neural Cell Production" and Indian Patent No. 229924 entitled, "A Composition for Increasing Neural Stem Cell Number and In Vitro Method of Using the Same".
First cGMP Feeder-independent Pluripotent Stem Cell Banks Released for Distribution
The WiCell Research Institute and the Waisman Clinical Biomanufacturing Facility announced recently the release of the first current Good Manufacturing Practices feeder-independent pluripotent stem cell banks available for sale and distribution to researchers worldwide.
|
|
|
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada |
|
|